当前位置: 首页 >> 检索结果
3702. Molecular Profiling Provides Clinical Insights Into Targeted and Immunotherapies as Well as Colorectal Cancer Prognosis.
作者: Linwei Guo.;Yunjin Wang.;Wenxiao Yang.;Chenchen Wang.;Tian'an Guo.;Jingcheng Yang.;Zhiming Shao.;Guoxiang Cai.;Sanjun Cai.;Liying Zhang.;Xin Hu.;Ye Xu.
来源: Gastroenterology. 2023年165卷2期414-428.e7页
Tumor genetic testing is indispensable in the management of primary and metastatic colorectal cancer (CRC), yet the indications for genomics-guided precision medicine and immunotherapy must be better understood and defined.
3703. Effect of Helicobacter pylori Eradication Therapy on the Incidence of Noncardia Gastric Adenocarcinoma in a Large Diverse Population in the United States.
作者: Dan Li.;Sheng-Fang Jiang.;Nan Ye Lei.;Shailja C Shah.;Douglas A Corley.
来源: Gastroenterology. 2023年165卷2期391-401.e2页
High-quality data regarding the effect of Helicobacter pylori eradication on the risk of noncardia gastric adenocarcinoma (NCGA) remain limited in the United States. We investigated the incidence of NCGA after H pylori eradication therapy in a large, community-based US population.
3705. Upper gastrointestinal endoscopic findings in functional constipation and irritable bowel syndrome diagnosed using the Rome IV criteria: a cross-sectional survey during a medical check-up in Japan.
作者: Koji Otani.;Toshio Watanabe.;Kanae Takahashi.;Yuji Nadatani.;Masaki Ominami.;Shusei Fukunaga.;Shuhei Hosomi.;Noriko Kamata.;Fumio Tanaka.;Yasuaki Nagami.;Koichi Taira.;Tatsuo Kimura.;Shinya Fukumoto.;Yasuhiro Fujiwara.
来源: BMC Gastroenterol. 2023年23卷1期140页
The Rome IV criteria have been established as an international standard for diagnosing disorders of gut-brain interaction. In this study, we aimed to examine the upper gastrointestinal (GI) endoscopic findings and symptoms of subjects with functional constipation (FC) and irritable bowel syndrome (IBS) of individuals undergoing a medical check-up.
3706. Efficacy observation of needle press needle combined with traditional Chinese medicine hot compress for postoperative nausea and vomiting intervention during anesthesia.3712. Clinical comparison of modified TEP technique with open preperitoneal approach and transabdominal preperitoneal repair for recurrent inguinal hernia.
作者: Xiaohuan Li.;Luping Xu.;Jie Zhang.;Qingqing Wang.;Qianhui Jin.
来源: Minerva Gastroenterol (Torino). 2023年69卷3期453-455页 3715. Clinical features and images of malignant lymphoma localized in the pancreatic head to differentiate from pancreatic ductal adenocarcinoma: a case series study.
作者: Naohiro Kato.;Atsushi Yamaguchi.;Syuhei Sugata.;Takuro Hamada.;Nao Furuya.;Takeshi Mizumoto.;Yuzuru Tamaru.;Ryusaku Kusunoki.;Toshio Kuwai.;Hirotaka Kouno.;Sho Tazuma.;Takeshi Sudo.;Miki Kido.;Takuo Ito.;Kazuya Kuraoka.;Hiroshi Kohno.
来源: BMC Gastroenterol. 2023年23卷1期138页
Pathological examination by endoscopic ultrasonography-guided fine-needle aspiration (EUS-FNA) has been reported to be useful in diagnosing pancreatic malignant lymphoma (ML), but some ML cases are difficult to be differentiated from pancreatic ductal adenocarcinoma (PDAC).
3716. Randomised clinical trial: 3-year interim analysis results of the VISION trial to evaluate the long-term safety of vonoprazan as maintenance treatment in patients with erosive oesophagitis.
作者: Ken Haruma.;Yoshikazu Kinoshita.;Takashi Yao.;Ryoji Kushima.;Junichi Akiyama.;Nobuo Aoyama.;Tatsuhiro Kanoo.;Kouji Miyata.;Naomi Kusumoto.;Naomi Uemura.
来源: BMC Gastroenterol. 2023年23卷1期139页
VISION is a randomised, phase 4, open-label, parallel-group, multicentre study conducted in 33 centres in Japan. The aim of this study was to assess the long-term safety of vonoprazan for maintenance treatment of healed erosive oesophagitis versus lansoprazole.
3717. Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study.
作者: Daniel Q Huang.;Laura A Wilson.;Cynthia Behling.;David E Kleiner.;Kris V Kowdley.;Srinivasan Dasarathy.;Maral Amangurbanova.;Norah A Terrault.;Anna Mae Diehl.;Naga Chalasani.;Brent A Neuschwander-Tetri.;Arun J Sanyal.;James Tonascia.; .;Rohit Loomba.
来源: Gastroenterology. 2023年165卷2期463-472.e5页
There are limited data regarding fibrosis progression in biopsy-proven nonalcoholic fatty liver disease (NAFLD) in people with type 2 diabetes mellitus (T2DM) compared with people without T2DM. We assessed the time to fibrosis progression in people with T2DM compared with people without T2DM in a large, multicenter, study of people with NAFLD who had paired liver biopsies.
|